This article was first published on Orbex Forex Trading Blog.
This content is synced from the rightful owners. Copyright on text and images belong to the original source.
Shares in US pharmaceutical company Pfizer have seen plenty of action over the last week. The company announced last week that itself and its German partner BioNTech had successfully proven their candidate COVID vaccine to be over 90% effective during months of clinical trials.
The two firms have been testing their drug on a large number of test patients (tens of thousands). They confirmed that the drug was seen to be effective (above 90%) and delivered no serious side effects.
Awaiting Regulatory Approval
Pfizer said that the drug will now be passed on for US approval. It expects to receive approval by the end of the month and will then be rolled out to governments.
The US and UK governments have both outlined plans to begin rolling the drug out ahead of the end of the year. Governments have a view to return their countries to normal by spring of 2021.
Rival Announcements Thwart Rally
Pfizer’s shares were initially seen shooting higher in response to the news with the company’s stock ...
To keep reading this article, please navigate to: Orbex Forex Trading Blog.